Implantation of a mitral allograft into the tricuspid valve position in active infective endocarditis
Related Experiment Video
Updated: Jun 10, 2025

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Ivan Ivanovich Skopin1, Mikhail Sergeevich Latyshev1, Dmitry Vacheslavovich Britikov1
1A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Ministry of Health of the Russian Federation, Rublevskoe Shosse, 135, Moscow, 121552 Russian Federation.
Abstract:
In cases of severe and recurrent infectious lesions affecting the right heart, one alternative option for bioprosthetic intervention is the implantation of a mitral allograft (a donor heart valve) in the position of the tricuspid valve. We present a clinical case detailing the successful implantation of a fresh mitral allograft into the tricuspid position in a 37-year-old male patient diagnosed with active infective endocarditis of the tricuspid valve and a high risk of prosthetic endocarditis. The mitral allograft was anatomically implanted with annuloplasty using an expanded polytetrafluoroethylene band. Subsequently, the patient was discharged in satisfactory condition. During the 9-month follow-up examination, no signs of infection were observed. Furthermore, the mitral allograft demonstrated excellent functionality, as evidenced by the absence of regurgitation and a mean pressure gradient measuring only 2 mmHg.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction

